Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

NCT04973007 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Oligometastatic Disease
Liver Metastases
Colorectal Cancer

Interventions

DRUG: Gadoxetate disodium
DRUG: Gadobenate dimeglumine

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]